CIK 0001728117
- Non-accelerated filer
- Smaller reporting company
Gossamer Bio, Inc.
Sign in to watch- Ticker
- GOSS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 475461709
- Phone
- +1 858-684-1300
- Business address
- 3115 MERRYFIELD ROW, SUITE 120, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 6 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-23 | Quisel John D Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2026-06-04 | Quisel John D Director | Grant or award · Stock Option (Right to Buy) | +115,000 | 115,000 | ||
| 2025-06-25 | Quisel John D Director | Grant or award · Stock Option (Right to Buy) | +115,000 | 115,000 | ||
| 2024-06-06 | Quisel John D Director | Grant or award · Non-qualified stock option (Right to Buy) | +115,000 | 115,000 | ||
| 2023-11-28 | Quisel John D Director | Grant or award · Stock Option (Right to Buy) | +230,000 | 230,000 |
Page 1 of 1 · 5 trades